Get started
VALBIOTISVALBIOTISVALBIOTIS

VALBIOTIS

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ALVAL chart


Full chart

Key stats


Market capitalization
‪21.94 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−7.37 M‬ EUR
Revenue (FY)
‪4.73 M‬ EUR
Shares float
‪15.12 M‬
Beta (1Y)
2.10

Employees


Employees (FY)
52
Change (1Y)
+4 +8.33%
Revenue / Employee (1Y)
‪91.02 K‬ EUR
Net income / Employee (1Y)
‪−141.69 K‬ EUR

About VALBIOTIS


Sector
Health Technology
Industry
Biotechnology
CEO
Sebastien M. Peltier
Website
valbiotis.com
Headquarters
Perigny
Founded
2014
ISIN
FR0013254851
FIGI
BBG00GQNQWV2
Valbiotis SA engages in the products and candidate drugs designed to prevent metabolic diseases. The company was founded on December 2, 2014 and is headquartered in Perigny, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ALVAL news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALVAL is 1.422 EUR — it has increased by 3.74% in the past 24 hours. Watch VALBIOTIS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange VALBIOTIS stocks are traded under the ticker ALVAL.
ALVAL stock has risen by 5.41% compared to the previous week, the month change is a 13.54% rise, over the last year VALBIOTIS has showed a −69.29% decrease.
We've gathered analysts' opinions on VALBIOTIS future price: according to them, ALVAL price has a max estimate of 8.00 EUR and a min estimate of 3.00 EUR. Watch ALVAL chart and read a more detailed VALBIOTIS stock forecast: see what analysts think of VALBIOTIS and suggest that you do with its stocks.
ALVAL reached its all-time high on Jun 14, 2017 with the price of 10.554 EUR, and its all-time low was 1.070 EUR and was reached on Jun 17, 2024. View more price dynamics on ALVAL chart.
See other stocks reaching their highest and lowest prices.
ALVAL stock is 7.35% volatile and has beta coefficient of 2.10. Track VALBIOTIS stock price on the chart and check out the list of the most volatile stocks — is VALBIOTIS there?
Today VALBIOTIS has the market capitalization of ‪21.91 M‬, it has increased by 1.61% over the last week.
Yes, you can track VALBIOTIS financials in yearly and quarterly reports right on TradingView.
ALVAL net income for the last half-year is ‪−3.50 M‬ EUR, while the previous report showed ‪−7.21 M‬ EUR of net income which accounts for 51.45% change. Track more VALBIOTIS financial stats to get the full picture.
No, ALVAL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 52.00 employees. See our rating of the largest employees — is VALBIOTIS on this list?
Like other stocks, ALVAL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VALBIOTIS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VALBIOTIS technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VALBIOTIS stock shows the sell signal. See more of VALBIOTIS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.